mch8k-011108.htm
UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
Washington,
D.C. 20549
FORM
8-K
Current
Report
Pursuant
to Section 13 or 15(d) of the
Securities
Exchange Act of 1934
Date
of
Report (date of earliest event reported): January 11, 2008
MILLENNIUM
CHEMICALS INC.
(Exact
name of registrant as specified in its charter)
Delaware
(State
or
other jurisdiction of incorporation)
|
1-12091
(Commission
File Number)
|
22-3436215
(I.R.S.
Employer Identification No.)
|
| |
|
|
Two
Greenville Crossing,
4001
Kennett Pike, Suite 238 Greenville, Delaware
(Address
of principal executive offices)
|
19807
(Zip
Code)
|
(713)
652-7200
(Registrant’s
telephone number, including area code)
Not
Applicable
(Former
Name or Former Address, if Changed Since Last Report)
Check
the
appropriate box below if the Form 8-K filing is intended to simultaneously
satisfy the filing obligation of the registrant under any of the following
provisions (see General
Instruction A.2. below):
o
Written communications pursuant to Rule 425 under the Securities Act (17 CFR
230.425)
o
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR
240.14a-12)
o
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange
Act
(17 CFR 240.14d-2(b))
o
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange
Act
(17 CFR 240.13e-4(c))
|
Item
1.02
|
Termination
of a Material Definitive Agreement
|
On
January 11, 2008, Millennium Chemicals Inc. (“Millennium Chemicals”) made
payments for conversion with respect to all of its remaining outstanding 4%
Convertible Senior Debentures issued under the Indenture dated as of November
25, 2003 among Millennium Chemicals, Millennium America Inc. (together with
Millennium Chemicals, “Millennium”) and The Bank of New York (as supplemented,
the “Indenture”), terminating all of the Millennium obligations under the
Indenture.
SIGNATURE
Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant
has
duly caused this report to be signed on its behalf by the undersigned hereunto
duly authorized.
MILLENNIUM
CHEMICALS INC.
By:/s/
Gerald A.
O’Brien
Name: Gerald
A. O’Brien
Title: Vice
President,
General
Counsel
Date: January
17, 2008